{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T01:34:43Z","timestamp":1791423283317,"version":"4.3.3"},"reference-count":23,"publisher":"Walter de Gruyter GmbH","issue":"2","license":[{"start":{"date-parts":[[2021,5,16]],"date-time":"2021-05-16T00:00:00Z","timestamp":1621123200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,5,16]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec id=\"j_jvetres-2021-0023_s_006\">\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Recombinant bovine interferon alpha (rBoIFN-\u03b1) has been demonstrated to have antiviral activity. However, no conduct of acute or chronic toxicity tests has been reported.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jvetres-2021-0023_s_007\">\n                    <jats:title>Material and Methods<\/jats:title>\n                    <jats:p>Specific pathogen-free Sprague Dawley rats were administered doses at different concentrations through intraperitoneal or intravenous injection. After the administration (single for an acute toxicity test over 14 days or daily for a sub-chronic toxicity test over 30 days), the rats\u2019 behaviour and other indicators and the degree of toxic reaction were continuously monitored. Blood was collected for haematological and serum biochemical examinations. At the end of the experiments, the rats were sacrificed for necropsy and histopathological tissue analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jvetres-2021-0023_s_008\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The external performance, behaviour characteristics, and changes in body temperature and body weight of the rats in each subgroup were comparable to the normal control subgroup. Except for a few cases, there were no lesions in the viscera\u2019s pathological structures, and the blood parameters and biochemical indicators were not noticeably different from those of the control subgroup.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"j_jvetres-2021-0023_s_009\">\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study suggests that rBoIFN-\u03b1 seems to be safe for rats, and its use may foster the development of the cattle industry in China by protecting livestock health.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2478\/jvetres-2021-0023","type":"journal-article","created":{"date-parts":[[2021,5,17]],"date-time":"2021-05-17T10:39:11Z","timestamp":1621247951000},"page":"183-192","source":"Crossref","is-referenced-by-count":4,"title":["Acute and sub-chronic toxicity study of recombinant bovine interferon alpha in rodents"],"prefix":"10.2478","volume":"65","author":[{"given":"Hai-Yang","family":"Yu","sequence":"first","affiliation":[{"name":"Department of Microbiology, Anhui Medical University, Hefei , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Mei","family":"Gao","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Third Affiliated Hospital of Anhui Medical University, Hefei , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhou","sequence":"additional","affiliation":[{"name":"Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-Bing","family":"Xia","sequence":"additional","affiliation":[{"name":"Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Yuan","family":"He","sequence":"additional","affiliation":[{"name":"Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min-Zhi","family":"Jiang","sequence":"additional","affiliation":[{"name":"Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Li","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Anhui Medical University, Hefei , Anhui Province , , P.R. China"},{"name":"Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Anhui Medical University, Hefei , Anhui Province , , P.R. China"},{"name":"Wuhu Interferon Bio-products Industry Research Institute Co., Ltd, Wuhu , Anhui Province , , P.R. China"},{"name":"Wuhu Overseas Students Pioneer Park, Wuhu , Anhui Province , , P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"374","published-online":{"date-parts":[[2021,5,16]]},"reference":[{"key":"2026042820523787171_j_jvetres-2021-0023_ref_001","doi-asserted-by":"crossref","unstructured":"Ameni A.Z., Latorre O.A., Torres L.M., G\u00f3rniak S.L.: Toxicity study about a medicinal plant Casearia sylvestris: A contribution to the Brazilian Unified Health System (SUS). J Ethnopharmacol 2015, 175, 9\u201313, doi: 10.1016\/j.jep.2015.08.027.","DOI":"10.1016\/j.jep.2015.08.027"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_002","doi-asserted-by":"crossref","unstructured":"Chinsangaram J., Piccone M.E., Grubman M.J.: Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha\/beta interferon. J Virol 1999, 73, 9891\u20139898, doi: 10.1128\/JVI.73.12.9891-9898.1999.","DOI":"10.1128\/JVI.73.12.9891-9898.1999"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_003","doi-asserted-by":"crossref","unstructured":"Dunn G.P., Koebel C.M., Schreiber R.D.: Interferons, immunity and cancer immunoediting. Nat Rev Immunol 2006, 6, 836\u2013848, doi:10.1038\/nri1961.","DOI":"10.1038\/nri1961"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_004","unstructured":"Edmonson J.H., Kovach J.S., Buckner J.C., Kvols L.K., Hahn R.G.: Phase I study of difluoromethylornithine in combination with recombinant alpha 2a-interferon. Cancer Res 1988, 48, 6584\u20136586."},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_005","doi-asserted-by":"crossref","unstructured":"Einhorn S., Strander H.: Is interferon tissue specific? Effect of human leukocyte and fibroblast interferons on the growth of lymphoblastoid and osteosarcoma cell lines. J Gen Virol 1977, 35, 573\u2013577, doi: 10.1099\/0022-1317-35-3-573.","DOI":"10.1099\/0022-1317-35-3-573"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_006","doi-asserted-by":"crossref","unstructured":"Goodkin D.E.: Interferon beta therapy for multiple sclerosis. Lancet 1998, 352, 1486\u20131487, doi: 10.1016\/S0140-6736(98)00057-9.","DOI":"10.1016\/S0140-6736(98)00057-9"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_007","doi-asserted-by":"crossref","unstructured":"Isaacs A., Lindenmann J.: Virus interference. I. The interferon. Proc R Soc Lond B Biol Sci 1957, 147, 258\u2013267, doi: 10.1098\/rspb.1957.0048.","DOI":"10.1098\/rspb.1957.0048"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_008","doi-asserted-by":"crossref","unstructured":"Kim H.-C., Kang B.-H., Ha C.-S., Han S.-S., Roh J.-K.: An acute toxicity study of recombinant human interferon alpha A (LBD-007) in Sprague-Dawley rats. J Toxicol Sci 1993, 18 Suppl 2, 37\u201342, doi: 10.2131\/jts.18.supplementii_37.","DOI":"10.2131\/jts.18.SupplementII_37"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_009","doi-asserted-by":"crossref","unstructured":"Koyama R., Arase Y., Ikeda K., Suzuki F., Suzuki Y., Saitoh S., Kobayashi M., Akuta N., Someya T., Hosaka T., Sezaki H., Kobayashi M., Kumada H.: Efficacy of interferon therapy in elderly patients with chronic hepatitis C. Intervirology 2006, 49, 121\u2013126, doi: 10.1159\/000089372.","DOI":"10.1159\/000089372"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_010","doi-asserted-by":"crossref","unstructured":"Li Y., Zhang X., Liang C., Hu J., Yu Z.: Safety evaluation of mulberry leaf extract: Acute, subacute toxicity and genotoxicity studies. Regul Toxicol Pharmacol 2018, 95, 220\u2013226, doi: 10.1016\/j.yrtph.2018.03.007.","DOI":"10.1016\/j.yrtph.2018.03.007"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_011","doi-asserted-by":"crossref","unstructured":"Marcus P.I., van der Heide L., Sekellick M.J.: Interferon action on avian viruses. I. Oral administration of chicken interferon-alpha ameliorates Newcastle disease. J Interferon Cytokine Res 1999, 19, 881\u2013885, doi: 10.1089\/107999099313406.","DOI":"10.1089\/107999099313406"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_012","doi-asserted-by":"crossref","unstructured":"Ohmann H.B., Gilchrist J.E., Babiuk L.A.: Effect of recombinant DNA-produced bovine interferon alpha (BoIFN-alpha 1) on the interaction between bovine alveolar macrophages and bovine herpesvirus type 1. J Gen Virol 1984, 65, 1487\u20131495, doi: 10.1099\/0022-1317-65-9-1487.","DOI":"10.1099\/0022-1317-65-9-1487"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_013","doi-asserted-by":"crossref","unstructured":"Organisation for Economic Co-operation and Development: Test No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents, OECD Guidelines for the Testing of Chemicals, Section 4. OECD Publishing, Paris, 2008, doi: 10.1787\/9789264070684-en.","DOI":"10.1787\/9789264070684-en"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_014","doi-asserted-by":"crossref","unstructured":"Shin J.-H., Moon H.-J., Kim T.-S., Kang I.H., Ki H.Y., Choi K.-S., Han S.-Y.: Repeated 28-day oral toxicity study of vinclozolin in rats based on the draft protocol for the \u201cEnhanced OECD Test Guideline No. 407\u201d to detect endocrine effects. Arch Toxicol 2006, 80, 547\u2013554, doi: 10.1007\/s00204-006-0080-6.","DOI":"10.1007\/s00204-006-0080-6"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_015","doi-asserted-by":"crossref","unstructured":"Tabarraei H., Hassan J., Parvizi M.R., Golshahi H., Keshavarz-Tarikhi H.: Evaluation of the acute and sub-acute toxicity of the black caraway seed essential oil in Wistar rats. Toxicol Rep 2019, 6, 869\u2013874, doi: 10.1016\/j.toxrep.2019.08.010.","DOI":"10.1016\/j.toxrep.2019.08.010"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_016","doi-asserted-by":"crossref","unstructured":"Thivolet J., Nicolas J.F., Kanitakis J., Lyonnet S., Chouvet B.: Recombinant interferon alpha 2a is effective in the treatment of discoid and subacute cutaneous lupus erythematosus. Br J Dermatol 1990, 122, 405\u2013409, doi: 10.1111\/j.1365-2133.1990.tb08290.x.","DOI":"10.1111\/j.1365-2133.1990.tb08290.x"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_017","doi-asserted-by":"crossref","unstructured":"Tu Y.B., Wang G., Wang Y.-Q., Chen W.-Y., Zhang L., Liu Y.-G., Jiang C.-G., Wang S.-J., Bu Z.-G., Cai X.-H.: Extracellular expression and antiviral activity of a bovine interferon-alpha through codon optimization in Pichia pastoris. Microbiol Res 2016, 191, 12\u201318, doi: 10.1016\/j.micres.2016.05.009.","DOI":"10.1016\/j.micres.2016.05.009"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_018","doi-asserted-by":"crossref","unstructured":"Van Wyk B., Snider M., Scruten E., Littel-van den Hurk S.V., Napper S.: Induction of functional interferon alpha and gamma responses during acute infection of cattle with non-cytopathic bovine viral diarrhea virus. Vet Microbiol 2016, 195, 104\u2013114, doi: 10.1016\/j.vetmic.2016.09.015.","DOI":"10.1016\/j.vetmic.2016.09.015"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_019","doi-asserted-by":"crossref","unstructured":"Vilar Gomez E., Gr\u00e1 Oramas B., Ar\u00fas Soler E., Ruenes Domech C., Davila Gonzalez Y.: Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B. Gastroenterol Hepatol 2006, 29, 534\u2013541.","DOI":"10.1157\/13094348"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_020","doi-asserted-by":"crossref","unstructured":"Wahid B., Shami K., Joiya S.A., Ozuyar S.E.G., Idrees M.: Comparing the risk of hypothyroidism in HCV patients treated with different DAA drugs combinations (sofosbuvir + interferon + ribavirin and sofosbuvir + daclatasvir + ribavirin). J Med Virol 2020, 92, 3868\u20133870, doi: 10.1002\/jmv.25931.","DOI":"10.1002\/jmv.25931"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_021","doi-asserted-by":"crossref","unstructured":"Walder C.E., Thiemermann C., Vane J.R.: Endothelium-derived relaxing factor participates in the increased blood flow in response to pentagastrin in the rat stomach mucosa. Proc Biol Sci 1990, 241, 195\u2013200, doi: 10.1098\/rspb.1990.0085.","DOI":"10.1098\/rspb.1990.0085"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_022","doi-asserted-by":"crossref","unstructured":"Yu H.-Y., Liu J., He Z.-Y., Zhou W., Xia B.-B., Wang M., Chen J., Wang M.-L., Jiang G.-T., Zhao J.: Soluble Expression, Rapid Purification and Antiviral Activity of Recimbinant Bovine Interferon-\u03b1 in Escherichia coli. Appl Biochem Microbiol 2020, 56, 154\u2013163, doi: 10.1134\/S0003683820020143.","DOI":"10.1134\/S0003683820020143"},{"key":"2026042820523787171_j_jvetres-2021-0023_ref_023","doi-asserted-by":"crossref","unstructured":"Zhao J., Yu H.Y., Zhang J.L., Wang X.M., Li J.P., Hu T., Hu Y., Wang M.L., Shen Y.Z., Xu J.D., Han G.X., Chen J.: Pharmacokinetic studies of the recombinant chicken interferon-alpha in broiler chickens. J Vet Med Sci 2017, 79, 314\u2013319, doi: 10.1292\/jvms.15-0681.","DOI":"10.1292\/jvms.15-0681"}],"container-title":["Journal of Veterinary Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/reference-global.com\/pdf\/10.2478\/jvetres-2021-0023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T23:36:00Z","timestamp":1777419360000},"score":1,"resource":{"primary":{"URL":"https:\/\/reference-global.com\/article\/10.2478\/jvetres-2021-0023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,16]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2021,5,16]]},"published-print":{"date-parts":[[2021,5,16]]}},"alternative-id":["10.2478\/jvetres-2021-0023"],"URL":"https:\/\/doi.org\/10.2478\/jvetres-2021-0023","relation":{},"ISSN":["2450-8608"],"issn-type":[{"value":"2450-8608","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,16]]}}}